• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 病毒载量作为 COVID-19 门诊和住院患者疾病严重程度的预测因子:一项前瞻性队列研究。

SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study.

机构信息

Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

出版信息

PLoS One. 2021 Oct 12;16(10):e0258421. doi: 10.1371/journal.pone.0258421. eCollection 2021.

DOI:10.1371/journal.pone.0258421
PMID:34637459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8509867/
Abstract

INTRODUCTION

We aimed to examine if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) cycle quantification (Cq) value, as a surrogate for SARS-CoV-2 viral load, could predict hospitalisation and disease severity in adult patients with coronavirus disease 2019 (COVID-19).

METHODS

We performed a prospective cohort study of adult patients with PCR positive SARS-CoV-2 airway samples including all out-patients registered at the Department of Infectious Diseases, Odense University Hospital (OUH) March 9-March 17 2020, and all hospitalised patients at OUH March 10-April 21 2020. To identify associations between Cq-values and a) hospital admission and b) a severe outcome, logistic regression analyses were used to compute odds ratios (OR) and 95% Confidence Intervals (CI), adjusting for confounding factors (aOR).

RESULTS

We included 87 non-hospitalised and 82 hospitalised patients. The median baseline Cq-value was 25.5 (interquartile range 22.3-29.0). We found a significant association between increasing Cq-value and hospital-admission in univariate analysis (OR 1.11, 95% CI 1.04-1.19). However, this was due to an association between time from symptom onset to testing and Cq-values, and no association was found in the adjusted analysis (aOR 1.08, 95% CI 0.94-1.23). In hospitalised patients, a significant association between lower Cq-values and higher risk of severe disease was found (aOR 0.89, 95% CI 0.81-0.98), independent of timing of testing.

CONCLUSIONS

SARS-CoV-2 PCR Cq-values in outpatients correlated with time after symptom onset, but was not a predictor of hospitalisation. However, in hospitalised patients lower Cq-values were associated with higher risk of severe disease.

摘要

简介

我们旨在研究严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)聚合酶链反应(PCR)循环定量(Cq)值是否可以作为SARS-CoV-2病毒载量的替代指标,来预测成人 2019 冠状病毒病(COVID-19)患者的住院和疾病严重程度。

方法

我们对 2020 年 3 月 9 日至 3 月 17 日在奥胡斯大学医院传染病科登记的所有 SARS-CoV-2 呼吸道样本 PCR 阳性的门诊成年患者,以及 2020 年 3 月 10 日至 4 月 21 日在奥胡斯大学医院住院的所有患者进行了前瞻性队列研究。为了确定 Cq 值与 a)住院和 b)严重结局之间的关联,我们使用逻辑回归分析计算了比值比(OR)和 95%置信区间(CI),并对混杂因素进行了调整(aOR)。

结果

我们纳入了 87 名非住院患者和 82 名住院患者。中位基线 Cq 值为 25.5(四分位距 22.3-29.0)。在单变量分析中,我们发现 Cq 值的增加与住院之间存在显著关联(OR 1.11,95%CI 1.04-1.19)。然而,这是由于症状出现到检测之间的时间与 Cq 值之间的关联,而在调整后的分析中则没有发现关联(aOR 1.08,95%CI 0.94-1.23)。在住院患者中,我们发现 Cq 值越低与严重疾病风险越高之间存在显著关联(aOR 0.89,95%CI 0.81-0.98),这与检测时间无关。

结论

门诊患者的 SARS-CoV-2 PCR Cq 值与症状出现后的时间相关,但不能预测住院。然而,在住院患者中,较低的 Cq 值与严重疾病的风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/cb172743c999/pone.0258421.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/2670d158b819/pone.0258421.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/bffc18575da8/pone.0258421.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/0ecb0a2363eb/pone.0258421.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/cb172743c999/pone.0258421.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/2670d158b819/pone.0258421.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/bffc18575da8/pone.0258421.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/0ecb0a2363eb/pone.0258421.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a013/8509867/cb172743c999/pone.0258421.g004.jpg

相似文献

1
SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study.SARS-CoV-2 病毒载量作为 COVID-19 门诊和住院患者疾病严重程度的预测因子:一项前瞻性队列研究。
PLoS One. 2021 Oct 12;16(10):e0258421. doi: 10.1371/journal.pone.0258421. eCollection 2021.
2
SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic.严重急性呼吸综合征冠状病毒 2 型感染:初始病毒载量(iVL)可预测疾病严重程度/结局,住院患者 iVL 的下降趋势与大流行的减缓相对应。
PLoS One. 2021 Sep 16;16(9):e0255981. doi: 10.1371/journal.pone.0255981. eCollection 2021.
3
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study.新西兰有症状非住院个体中SARS-CoV-2病毒载量动态及实时逆转录聚合酶链反应循环阈值解读:一项多中心横断面观察性研究
Pathology. 2021 Jun;53(4):530-535. doi: 10.1016/j.pathol.2021.01.007. Epub 2021 Mar 20.
4
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.德国一家三级保健中心在 SARS-CoV-2 大流行第一波期间住院 COVID-19 患者的临床和病毒学特征:一项前瞻性观察研究。
Infection. 2021 Aug;49(4):703-714. doi: 10.1007/s15010-021-01594-w. Epub 2021 Apr 22.
5
Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study.入院时 SARS-CoV-2 病毒载量与院内急性肾损伤的关系:一项回顾性队列研究。
PLoS One. 2021 Feb 24;16(2):e0247366. doi: 10.1371/journal.pone.0247366. eCollection 2021.
6
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome.鼻咽拭子中的 SARS-CoV-2 病毒载量不是不良结局的独立预测因子。
Sci Rep. 2021 Jun 21;11(1):12931. doi: 10.1038/s41598-021-92400-y.
7
Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19.SARS-CoV-2 聚合酶链反应的循环阈值与 COVID-19 患者计算机断层扫描总严重程度评分的关系。
Int J Infect Dis. 2020 Dec;101:160-166. doi: 10.1016/j.ijid.2020.09.1449. Epub 2020 Sep 28.
8
Risk Factors for Severe COVID-19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020-2022.2020-2022 年南非急性呼吸道感染哨点监测中纳入的儿童和青少年发生严重 COVID-19 的危险因素。
Influenza Other Respir Viruses. 2024 May;18(5):e13300. doi: 10.1111/irv.13300.
9
SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality.急诊科鼻咽拭子中 SARS-CoV-2 病毒载量不能预测 COVID-19 的严重程度和死亡率。
Acad Emerg Med. 2021 Mar;28(3):306-313. doi: 10.1111/acem.14217. Epub 2021 Feb 5.
10
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.诊断 SARS-CoV-2 循环阈值预测 COVID-19 症状患者的疾病严重程度、生存率和六个月后遗症。
Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.

引用本文的文献

1
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with lung infection and tissue-damage biomarkers.血浆严重急性呼吸综合征冠状病毒2核衣壳抗原水平与肺部感染及组织损伤生物标志物相关。
Virus Res. 2025 Jun;356:199580. doi: 10.1016/j.virusres.2025.199580. Epub 2025 May 12.
2
Differential immunoregulation by human surfactant protein A variants determines severity of SARS-CoV-2-induced lung disease.人表面活性蛋白A变体的差异性免疫调节决定了SARS-CoV-2诱导的肺部疾病的严重程度。
Front Immunol. 2025 Apr 2;16:1462278. doi: 10.3389/fimmu.2025.1462278. eCollection 2025.
3
SARS-CoV-2 viremia but not respiratory viral load is associated with respiratory complications in patients with severe COVID-19.

本文引用的文献

1
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?2019 冠状病毒病患者的系统性炎症标志物与心理物理学嗅觉评分:是否存在相关性?
J Laryngol Otol. 2021 Aug;135(8):723-728. doi: 10.1017/S0022215121001651. Epub 2021 Jun 29.
2
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes.居住在养老院中的 SARS-CoV-2 感染者的感染、症状发展和死亡率的预测因素。
PLoS One. 2021 Mar 16;16(3):e0248009. doi: 10.1371/journal.pone.0248009. eCollection 2021.
3
Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.
严重 COVID-19 患者的 SARS-CoV-2 病毒血症而非呼吸道病毒载量与呼吸道并发症相关。
BMC Pulm Med. 2024 Jul 29;24(1):366. doi: 10.1186/s12890-024-03183-7.
4
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.SARS-CoV-2 病毒载量在未接种疫苗个体首次感染时的鼻咽部:四项随机试验的二次交叉方案分析。
JAMA Netw Open. 2024 May 1;7(5):e2412835. doi: 10.1001/jamanetworkopen.2024.12835.
5
Differentiating patients admitted primarily due to coronavirus disease 2019 (COVID-19) from those admitted with incidentally detected severe acute respiratory syndrome corona-virus type 2 (SARS-CoV-2) at hospital admission: A cohort analysis of German hospital records.在医院入院时区分主要因 2019 年冠状病毒病(COVID-19)而入院的患者和因偶然发现的严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)而入院的患者:德国医院记录的队列分析。
Infect Control Hosp Epidemiol. 2024 Jun;45(6):746-753. doi: 10.1017/ice.2024.3. Epub 2024 Feb 14.
6
A stronger antibody response in increased disease severity of SARS-CoV-2.在 SARS-CoV-2 疾病严重程度增加的情况下,抗体反应增强。
BMC Infect Dis. 2024 Jan 2;24(1):17. doi: 10.1186/s12879-023-08923-4.
7
Clinical course and management of COVID-19 in the era of widespread population immunity.广泛人群免疫时代下的 COVID-19 临床病程和管理。
Nat Rev Microbiol. 2024 Feb;22(2):75-88. doi: 10.1038/s41579-023-01001-1. Epub 2023 Dec 19.
8
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience.瑞德西韦对COVID-19住院患者鼻咽拭子标本中SARS-CoV-2 RNA病毒载量动力学的影响:一项真实病例经验
Microorganisms. 2023 Jan 25;11(2):312. doi: 10.3390/microorganisms11020312.
9
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients.症状出现后六个月,中和 SARS-CoV-2 抗体的高滴度与 COVID-19 住院患者的病情加重有关。
Virol J. 2023 Jan 25;20(1):14. doi: 10.1186/s12985-023-01974-8.
10
Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2.一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的病毒样颗粒疫苗单价和二价制剂的免疫原性和有效性
Vaccines (Basel). 2022 Nov 24;10(12):1997. doi: 10.3390/vaccines10121997.
丹麦一家三级医院中 COVID-19 住院患者的死亡率较低。
Int J Infect Dis. 2021 Jan;102:212-219. doi: 10.1016/j.ijid.2020.10.018. Epub 2020 Oct 12.
4
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy.意大利撒丁岛住院 COVID-19 患者的临床特征、实验室检查结果和死亡预测因素。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7861-7868. doi: 10.26355/eurrev_202007_22291.
5
A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19.COVID-19背景下循环阈值临床效用的系统评价
Infect Dis Ther. 2020 Sep;9(3):573-586. doi: 10.1007/s40121-020-00324-3. Epub 2020 Jul 28.
6
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
7
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.Cepheid Xpert Xpress 和 Abbott ID Now 与 Roche cobas 用于 SARS-CoV-2 快速检测的比较。
J Clin Virol. 2020 Jul;128:104428. doi: 10.1016/j.jcv.2020.104428. Epub 2020 May 13.
8
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.七种用于 COVID-19 的商业 RT-PCR 诊断试剂盒的比较。
J Clin Virol. 2020 Jul;128:104412. doi: 10.1016/j.jcv.2020.104412. Epub 2020 May 8.
9
Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test.罗氏 cobas 6800 SARS-CoV-2 检测与实验室开发的实时 RT-PCR 检测对鼻咽拭子样本中 SARS-CoV-2 的检测比较。
J Med Virol. 2020 Sep;92(9):1695-1698. doi: 10.1002/jmv.25988. Epub 2020 May 22.
10
Comparison of Commercially Available and Laboratory-Developed Assays for Detection of SARS-CoV-2 in Clinical Laboratories.临床实验室中用于检测新型冠状病毒2的商用检测方法与实验室自行开发检测方法的比较
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00821-20.